Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest emphysema Stories

2011-10-17 20:32:10

A protein critical to development appears to have a grave impact on lungs exposed to smoking and air pollution, researchers report. Blocking that protein, called calpain, in the lungs may prove an effective way to avoid narrow, scarred blood vessels and pulmonary hypertension, said Dr. Yunchao Su, pharmacologist at Georgia Health Sciences University. "Calpain enables the bad behavior that occurs in pulmonary hypertension," said Su, corresponding author of the study published in the...

2011-10-13 11:42:10

By studying mice exposed to tobacco smoke for a period of months, researchers have new insight into how emphysema and chronic obstructive pulmonary disease (COPD) develops. In the October 14th issue of Cell, a Cell Press publication, they also report a promising new way to reverse the lung damage underlying these conditions. "It has not been very clear what causes the disease and there has been no therapy to stop or reverse lung destruction in emphysema," said Norbert Weissman of the...

2011-10-06 10:23:00

CHICAGO, Oct. 6, 2011 /PRNewswire-USNewswire/ -- Data released with the 2010 Illinois Behavioral Risk Factor Surveillance Survey (BRFSS) shows that more than 60% of the people living with chronic obstructive pulmonary disease (COPD) experience shortness of breath so severe that it affects their quality of life. COPD is caused by airflow blockage and damaged lung tissue, and it includes chronic bronchitis and emphysema. It is the third leading cause of death in the U.S. People living with...

2011-09-26 02:03:00

AMSTERDAM and TUSTIN, Calif., Sept. 26, 2011 /PRNewswire/ -- Uptake Medical® today announced it has received the CE Mark (Conformite Europeenne) for the InterVapor(TM) System - the first endoscopic lung volume reduction system for the treatment of severe emphysema that uses the body's natural healing processes without leaving foreign materials behind. The CE Mark will allow Uptake Medical to commercialize InterVapor in key markets within the European Community. This...

2011-09-19 09:20:00

CORALVILLE, Iowa, Sept. 19, 2011 /PRNewswire/ -- VIDA Diagnostics, a leading developer of quantitative pulmonary imaging software, announced today that the company has achieved International Organization for Standardization (ISO 13485) certification and CE certification for its flagship product, Apollo®. The CE certification permits VIDA to sell Apollo for clinical use in the European Economic Area (EEA) and Switzerland. Apollo currently has FDA 510(k) approval for...

2011-09-06 07:03:00

TUSTIN, Calif., Sept. 6, 2011 /PRNewswire/ -- Uptake Medical® Corp., maker of InterVapor(TM), a minimally invasive treatment for severe emphysema, today announced that seasoned medical device executive Lloyd Mencinger has joined the company as European General Manager, effective September 1, 2011. Mr. Mencinger joins Uptake Medical with nearly three decades of broad functional experience with medical device leaders such as Boston Scientific, Baxter, and American Hospital...

2011-07-28 01:05:46

Using computed tomography (CT), researchers have identified two types of structural changes in the lungs of patients with chronic obstructive pulmonary disease (COPD) that are associated with frequent exacerbations, or episodes when symptoms suddenly worsen. Their findings are published online in the journal Radiology. COPD can damage both the airways and the air sacs of the lungs, and is a leading cause of death and illness worldwide. The two main structural abnormalities seen in COPD are...

2011-07-15 14:53:35

Telomeres, the body's own cellular clocks, may be a crucial factor underlying the development of emphysema, according to research from Johns Hopkins University. "We found that in mice that have short telomeres, there was a significant increased risk of developing emphysema after exposure to cigarette smoke," said Mary Armanios, MD, assistant professor of oncology at the Johns Hopkins School of Medicine. The study appears online ahead of the print edition of the American Journal of Respiratory...

2011-07-09 00:00:32

Dr. Martin Garcia-Bunuel, deputy director of the Managed Care Clinical Center at the VA Maryland Health Care System, offers some tips for people with lung disease to breathe easier in summer. Baltimore, MD (PRWEB) July 07, 2011 Summer heat, spikes in pollution, fires, smoke and other events causing poor air quality makes breathing a challenge for people with compromised lungs, such as those suffering from asthma, chronic obstructive pulmonary disease COPD, emphysema, and chronic...

2011-07-01 15:12:00

SILVER SPRING, Md., July 1, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Arcapta Neohaler (indacaterol inhalation powder) for the long term, once-daily maintenance bronchodilator treatment of airflow obstruction in people with chronic obstructive pulmonary disease (COPD) including chronic bronchitis and/or emphysema. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) COPD is a serious lung disease that makes breathing difficult. Symptoms...


Latest emphysema Reference Libraries

Lung
2013-01-01 15:53:59

The lung is a vital organ that is a part of the respiratory system. Generally a person has two lungs; however, the body can function with only one. The lung’s main function is to move oxygen and carbon dioxide into and out of the bloodstream through gas exchange. The lungs are located lateral to the heart in the thoracic cavity. Each lung has a tip called the apex, which is superior in the body. The bases of the lungs rest on the diaphragm. They appear to be spongy due to their bundles of...

More Articles (1 articles) »